Biotechnology News Magazine

Biotechnology News Magazine is one of the industry’s leading sources for biotech industry news!

Biotechnology News Magazine reports the latest biotech, pharma, FDA updates, biotechnology clinical trials, biotechnology mergers, biotechnology acquisitions, biotechnology funding, articles of interest and other important news.

Biotech executives, investors, and other allied health professionals have access to Biotechnology News Magazine through a complimentary subscription. Furthermore, as patients become more pro-active in researching various medical diseases and conditions, we are proud to boast they are subscribers of our publication as well.

We hope you find value in Biotechnology News Magazine’s overall purpose and objectives. BiotechnologyNews Magazine is the authoritative voice of biotechnology, bridging the industry to healthcare professionals, academia, government, venture capitalists, and the general public.

If you have any questions or comments, please feel free to contact us. Biotechnology News Magazine is a fast, 1,2,3, easy read! LEARN MORE.

Latest Biotech Industry News

Risk From Pharma Reps Using Unapproved Content and Messaging in the Field Persists, but a Focus on Training Could Be the Answer

February 23, 2023

ACTO advises Study Reveals 50% of respondents in leadership roles catch incidents of field reps using unapproved content, but a continuous learning culture could eliminate this behavior.

Ginkgo Bioworks Announces Pathogen Monitoring Program at Kigali International Airport

February 15, 2023

Gingo Bioworks notes the program establishes a new node in a global early warning network for emerging variants to support timely and targeted public health response

DocSun Biomedical Limited Completes Technology Transfer to Future Now Biotech LLC

February 15, 2023

"We are thrilled to be transferring our tech and IPs to Future Now," said Mike Chen, CEO of DocSun Biomedical. "Our two companies share a common goal of improving healthcare and advancing medical technology, and this transfer will allow us to continue our mission on a larger scale."

Mergers/Acquisitions/Funding

Russell Finex Helps Leading Pharmaceutical Company Meet High Levels Of Demand With The Russell Compact Sieve

February 21, 2023

To ensure the highest quality final product, the company reached out to Russell Finex for a high-capacity vibrating screen. After assessing the company’s requirements, Russell Finex recommended the Russell Compact Sieve® as the ideal solution for check-screening pharmaceutical powders due to its stainless-steel contact parts, and easy-to-clean strip down design.

EuMentis Therapeutics Inc. Announces the First Closing of a Targeted $40M Series B Financing to Advance Novel Therapeutics to Treat Autism Spectrum Disorder, Tourette Syndrome and Traumatic Brain Injury

February 15, 2023

EuMentis plans to initiate Phase 2 clinical trials with EM-113 in autism spectrum disorder (ASD) and EM-221 in Tourette syndrome (TS) in 2nd half of this year

Clinical Trials, Studies, Data

Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes

February 8, 2023

Creative Medical Technology reaches next clinical trial milestone for treatment of Type 1 Diabetes with the first novel allogenic cellular therapy in the dorsal artery of the pancreas in the United States.

Nectin Therapeutics to Collaborate with Merck on Clinical Trial of Anti-PVR Antibody NTX1088 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced and Metastatic Solid Tumors

February 7, 2023

NTX1088 is a First-in-Class and highly potent monoclonal antibody directed against PVR (CD155), a transmembrane protein expressed on cancer cells and associated with resistance to PD1 and PDL1 immune checkpoint inhibitors.

Views from Our Experts

How Biotech Businesses Can Benefit from Freelance Experts

February 21, 2023

Ashmita Das, CEO of open talent platform Kolabtree, shares some of Kolabtree freelancer’s success stories.

FDA Updates

Unravel Biosciences Reports Positive Feedback from FDA Pre-Ind Meeting on RVL001 RETT Syndrome Program

February 15, 2023

Richard Novak, Ph.D., Unravel Bioscience Co-Founder and CEO. "The successful completion of this key development milestone provides a great validation of Unravel's ability to rapidly move promising therapies into the clinic, much faster than most conventional approaches to drug development."

ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA

February 8, 2023

In addition, ADMA BioCenters remains on-track to have all 10 plasma collection centers FDA-licensed by year-end 2023.

Executives on the Move

ImmPACT Bio Appoints Biren Amin, M.B.A. to its Board of Directors

February 8, 2023

Biren Amin has been the chief financial officer (CFO) and chief strategy officer of Pyramid Biosciences, Inc. since August 2022. He also serves as a co-director on the board of trustees of Axiom REACH Foundation, a non-profit organization focused on addressing public health disparities.

BerGenBio Announces the Establishment of Oncology Scientific Advisory Board

February 2, 2023

"We are very proud and honored to have assembled a group of leading international NSCLC experts to guide us as we investigate bemcentinib in 1st line NSCLC STK11m in combination with today's standard of care," said Cristina Oliva, M.D., Chief Medical Officer of BerGenBio. "Their expertise will play an integral role in our evaluation of bemcentinib and its potential to provide significant benefits to patients who today face a particularly poor prognosis."